Cost–benefit Comparison of Liraglutide and Sitagliptin in the Treatment of Type 2 Diabetes in Thailand
ClinicoEconomics and Outcomes Research - New Zealand
doi 10.2147/ceor.s201951
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2019
Authors
Publisher
Informa UK Limited